HOME >> BIOLOGY >> NEWS
Secondary complications and restoration of function in SCI

>

Variable-frequency-train (VFT) stimulation has received considerable interest for countering the fatigue that occurs in the muscles of able-bodied individuals during functional electrical stimulation. There is also much interest in using electrical stimulation for the rehabilitation of individuals with SCI. This study investigated the effectiveness of VFT stimulation on reducing quadriceps muscle fatigue in persons with complete SCI. The data provide the first evidence that VFT stimulation may not be effective at reducing fatigue without prior conditioning with electrical stimulation. The results may lead to an improved clinical use of electrical stimulation.

Portable neuromuscular stimulator aids exercise and mobility for individuals with paraplegia (pg 41)

Over the past 25 years, functional electrical stimulation has become a viable rehabilitative tool for the paraplegic population. The design and development of a portable, neuromuscular stimulator for use by individuals with paraplegia is described in this article. Potential uses of the neuromuscular stimulator include exercise, mobility and preventive skin care. The stimulator passed all relevant safety and reliability testing, making it suitable for home use.

Neostigmine and glycopyrrolate promote bowel movement (pg 53)

This study assessed the effects of neostigmine alone or neostigmine combined with glycopyrrolate on pulmonary suppression in individuals with SCI. The data suggest that although neostigmine promoted bowel movement, it also caused bronchoconstriction, which may worsen a weak respiratory system. When neostigmine is combined with glycopyrrolate, bowel movement is facilitated while bronchoconstriction is prevented. For patients with SCI who require bowel evacuation assistance, neostigmine and glycopyrrolate should be administered in combination.

Bronchodilator responses to metaproterenol sulfate among subjects with spinal cord injury (pg 59)<
'"/>

Contact: Judith LaVoie
judith@vard.org
410-962-1800 x 229
VA Research Communications Service
20-Feb-2004


Page: 1 2 3 4 5

Related biology news :

1. Women who drink may be at greater risk of cardiovascular complications than men
2. Remote monitoring of ICU patients lowers mortality rates, complications
3. Fetal and birth complications increase mental illness risks
4. Substance used to treat complications from diabetes also proves to work as antioxidant
5. Bush signs; ozone treatment for ballast water; wetland restoration template goes national
6. Traditional floodplain forest restoration may decrease bird diversity
7. Answers to Florida bay restoration are clear as mud!
8. Wave of the future? Dams as river restoration
9. Experts meet to evaluate watershed restoration for salmon in Pacific rivers
10. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
11. Fossil genes reveal how life sheds form and function

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Secondary complications and restoration function SCI

(Date:7/8/2015)... LAKES , N.J. and NEW YORK ... Company) and Guidepoint today announced BD ... start-up healthcare companies with free access to Guidepoint,s expert ... several start-ups that are developing cutting-edge technologies to improve ... a dedicated Guidepoint research manager, each start-up entrepreneur will ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... a field clinical study of its canine osteoarthritis stem cell product, currently under ... (Kansas City, KS) and will be marketed in the US by Aratana. This ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
Cached News: